|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Insmed (NASDAQ: INSM) through any online brokerage.
The latest price target for Insmed (NASDAQ: INSM) was reported by Cantor Fitzgerald on October 8, 2021. The analyst firm set a price target for 60.00 expecting INSM to rise to within 12 months (a possible 122.55% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Insmed (NASDAQ: INSM) is $26.96 last updated Thu Dec 02 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Insmed.
Insmed’s $Q4 earnings are confirmed for after-market on February 24, 2022.
There is no upcoming split for Insmed.
Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.